In GC, CYP1B1 expression was observed to increase with tumor stage and grade, and it was highly correlated with tumor-related fibroblast numbers, immunological checkpoints, microsatellite instability, tumor mutation burden (TMB), and neoantigens. Here, CYP1B1 is linked to neoplasm.